The IPO listings of Ganesh Infraworld and Suraksha Diagnostic are highly anticipated, as both companies have generated substantial interest in the market, with their shares set to list on December 6, 2024. These IPOs reflect strong investor confidence, each with a different focus and market potential.

Suraksha Diagnostic IPO Overview

Established in 1992, Suraksha Diagnostic has a robust presence in Kolkata, offering comprehensive pathology and radiology services. Their strategic positioning in Eastern and Northeastern India, coupled with their reputable service network, has poised them for further growth in the rapidly expanding diagnostic services market.

• IPO Details: The IPO raised ₹846.24 Crores, consisting entirely of an Offer for Sale (OFS) of 191.89 Lakh shares. The price band for the shares is set between ₹420 and ₹441, with the listing slated for December 6, 2024.
• Market Capitalization: At the upper price band of ₹441, the company's market capitalization will be ₹2,296.76 Crores.
• Subscription Status: Suraksha Diagnostic was subscribed 1.26 times by the final day of its subscription period. Despite this relatively modest subscription, the stock is expected to be of interest due to the growing demand for diagnostic services.
• Objectives: The offer proceeds will be entirely received by the selling shareholders. Suraksha will not be receiving any funds from this public offering.

Suraksha Diagnostic's market reputation, combined with its established presence in the East, gives it a competitive edge in the regional diagnostic market. The Grey Market Premium (GMP) has been reported as ₹0, suggesting a lack of significant trading interest or price discovery in the unorganized market.

Ganesh Infraworld IPO Overview

Ganesh Infraworld, formerly known as Ganesh International, is recognized as one of the fastest-growing startups in Eastern India, specializing in offering EPC services to large-scale infrastructure projects. The company’s broad spectrum of services includes civil, electrical, road, rail, and water infrastructure.

• IPO Details: The IPO raised ₹98.57 Crores, entirely through a Fresh Issue of 118.76 Lakh shares. The price band is set between ₹78 and ₹83, and the shares will also list on December 6, 2024.
• Market Capitalization: The company’s market capitalization at the upper price band of ₹83 will be ₹354.58 Crores.
• Subscription Status: Ganesh Infraworld’s IPO was oversubscribed by an impressive 326.16 times, showing tremendous demand. This high subscription indicates strong market sentiment, particularly among institutional investors.
• Objectives: The fresh issue proceeds will be utilized for long-term working capital requirements and general corporate purposes.

The Grey Market Premium (GMP) for Ganesh Infraworld has been reported at ₹25, suggesting an expected price rise on listing. The massive subscription rate coupled with the GMP indicates a positive sentiment around the stock.

Comparison and Key Insights

Both companies operate in industries with significant growth potential: Suraksha Diagnostic in the healthcare sector and Ganesh Infraworld in infrastructure services. While Suraksha Diagnostic is poised for steady growth due to increasing healthcare needs in Eastern India, Ganesh Infraworld benefits from the boom in infrastructure projects across the region.

• Retail Investment: Retail investors will be required to invest a minimum of ₹14,994 in Suraksha Diagnostic, and ₹1,32,800 in Ganesh Infraworld, which reflects the differing scale and target investor base of the two companies.
• GMP Analysis: The higher GMP for Ganesh Infraworld (₹25) indicates stronger demand in the grey market compared to Suraksha Diagnostic, where no GMP has been reported.

IPO Allotment Status and How to Check

Both Ganesh Infraworld and Suraksha Diagnostic IPOs will have their allotment statuses available online on December 4, 2024. Investors can check the allotment status by visiting the registrar websites and submitting the necessary details such as application number or PAN.

Conclusion

Both IPOs are positioned for an exciting debut on December 6, 2024, with Ganesh Infraworld showing stronger subscription numbers and Suraksha Diagnostic offering exposure to the growing diagnostic services sector in Eastern India. Investors can look forward to potential listing gains, especially for Ganesh Infraworld given its GMP and subscription performance.